A detailed history of Schonfeld Strategic Advisors LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 593,039 shares of PRME stock, worth $2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
593,039
Previous 818,518 27.55%
Holding current value
$2 Million
Previous $2.02 Million 62.54%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$2.73 - $5.56 $615,557 - $1.25 Million
-225,479 Reduced 27.55%
593,039 $3.29 Million
Q2 2025

Aug 14, 2025

BUY
$1.15 - $2.65 $941,295 - $2.17 Million
818,518 New
818,518 $2.02 Million
Q1 2024

May 15, 2024

BUY
$6.35 - $9.39 $2.1 Million - $3.1 Million
330,500 New
330,500 $2.31 Million

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $323M
More about PRME
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.